Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Tashchilova

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Computational and Structural Biotechnology Journal|October 6, 2025
DrugForm-DTA: Towards real-world drug-target binding affinity modelIvan Khokhlov, Anna Tashchilova, Nikolai Bugaev-Makarovskiy, et al.
Molecular Informatics|November 3, 2022
Experimentally Validated Novel Factor XIIa Inhibitors Identified by Docking and Quantum Chemical Post-processingIvan Ilin, Nadezhda Podoplelova, Alexey Sulimov, et al.
Computational and Structural Biotechnology Journal|May 20, 2026
DrugForm-TAS: Target-Agnostic Selectivity as Proteome-wide Binding Propensity EstimationAnna Tashchilova, Ivan Khokhlov, Alexey Seikin, et al.
Molecules (Basel, Switzerland)|April 25, 2020
Synthesis, Docking, and In Vitro Anticoagulant Activity Assay of Hybrid Derivatives of Pyrrolo[3,2,1-<i>ij</i>]Quinolin-2(1<i>H</i>)-one as New Inhibitors of Factor Xa and Factor XIaNadezhda Novichikhina, Ivan Ilin, Anna Tashchilova, et al.
Molecules (Basel, Switzerland)|February 25, 2022
New Blood Coagulation Factor XIIa Inhibitors: Molecular Modeling, Synthesis, and Experimental ConfirmationAnna Tashchilova, Nadezhda Podoplelova, Alexey Sulimov, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Computational and Structural Biotechnology Journal|October 6, 2025
DrugForm-DTA: Towards real-world drug-target binding affinity modelIvan Khokhlov, Anna Tashchilova, Nikolai Bugaev-Makarovskiy, et al.
Molecular Informatics|November 3, 2022
Experimentally Validated Novel Factor XIIa Inhibitors Identified by Docking and Quantum Chemical Post-processingIvan Ilin, Nadezhda Podoplelova, Alexey Sulimov, et al.
Computational and Structural Biotechnology Journal|May 20, 2026
DrugForm-TAS: Target-Agnostic Selectivity as Proteome-wide Binding Propensity EstimationAnna Tashchilova, Ivan Khokhlov, Alexey Seikin, et al.
Molecules (Basel, Switzerland)|April 25, 2020
Synthesis, Docking, and In Vitro Anticoagulant Activity Assay of Hybrid Derivatives of Pyrrolo[3,2,1-<i>ij</i>]Quinolin-2(1<i>H</i>)-one as New Inhibitors of Factor Xa and Factor XIaNadezhda Novichikhina, Ivan Ilin, Anna Tashchilova, et al.
Molecules (Basel, Switzerland)|February 25, 2022
New Blood Coagulation Factor XIIa Inhibitors: Molecular Modeling, Synthesis, and Experimental ConfirmationAnna Tashchilova, Nadezhda Podoplelova, Alexey Sulimov, et al.
Pageof 1